Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis https://t.co/wD3EF3zydE
Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2021 – Dec 2025Where it's discussed
-
YouTube3 videos
-
X / Twitter1 posts
AI synopsis
What people are saying
Discussions highlight the significance of the findings, with posts mentioning improvements in pelvic pain and mast cell reduction, using words like 'promising' and 'important,' which reflect genuine interest and recognition of potential impact. Readers navigate a balance between curiosity and cautious optimism, underscored by phrases that acknowledge the research's relevance without overstating immediate clinical applications.
Most discussions express support or curiosity about the findings, indicating agreement that ESWT shows promise.
Participants seem somewhat interested, posing questions or acknowledging the potential benefits without extensive controversy.
The conversations include brief references to methodology and implications, showing moderate engagement.
The overall tone suggests recognition that this research could influence future treatments, though not yet transformative.
Abstract in brief
- This study investigates how different energy levels of extracorporeal shock wave therapy (ESWT) impact the reduction of pelvic pain and mast cell activity in a rat model of chronic prostatitis/chronic pelvic pain syndrome (CPCPPS).
- The research found that ESWT with an energy flux density of 0.02 mJ/mm² was most effective in alleviating pelvic pain and prostate damage, likely by decreasing both total and degranulated mast cells.
- These findings suggest that choosing the appropriate ESWT energy level, specifically 0.02 mJ/mm², can improve treatment outcomes for managing pelvic pain associated with CPCPPS.]
Top posts
Most liked on X and BlueskyAll mentions
보톡스와 최고 조합인 OOO 탄력 치료? 2편
Extracorporeal Shock Wave Therapy for Spasticity Treatment and Muscle Reduction
Recent advances show ESWT as a safe, effective method for reducing muscle spasticity, with benefits lasting 4 to 6 weeks. The therapy influences neuromuscular mechanisms and can be used alongside botulinum toxin for…
Recent Advances in Extracorporeal Shock Wave Therapy for Spasticity Treatment
This video explores the use of extracorporeal shock wave therapy (ESWT) for reducing muscle spasticity post-neurological injury, highlighting recent research on its mechanisms, application types, duration of effects…
Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis https://t.co/wD3EF3zydE
M